-
Something wrong with this record ?
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer
EL. O'Dowd, I. Tietzova, E. Bartlett, A. Devaraj, J. Biederer, M. Brambilla, A. Brunelli, J. Chorostowska, H. Decaluwe, D. Deruysscher, W. De Wever, M. Donoghue, A. Fabre, M. Gaga, W. van Geffen, G. Hardavella, HU. Kauczor, A. Kerpel-Fronius, J....
Language English Country Germany
Document type Review, Journal Article
Grant support
TF-2019-14
European Respiratory Society
NLK
Free Medical Journals
from 1987
Medline Complete (EBSCOhost)
from 2012-11-01 to 1 year ago
PubMed
37804174
DOI
10.1093/ejcts/ezad302
Knihovny.cz E-resources
- MeSH
- Early Detection of Cancer methods MeSH
- Expressed Sequence Tags MeSH
- Humans MeSH
- Lung Neoplasms * diagnostic imaging MeSH
- Incidental Findings MeSH
- Tomography, X-Ray Computed methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that will ensure clinical and cost effectiveness. This European Respiratory Society (ERS) task force was formed to provide an expert consensus for the management of incidental findings which can be adapted and followed during implementation. METHODS: A multi-European society collaborative group was convened. 23 topics were identified, primarily from an ERS statement on lung cancer screening, and a systematic review of the literature was conducted according to ERS standards. Initial review of abstracts was completed and full text was provided to members of the group for each topic. Sections were edited and the final document approved by all members and the ERS Science Council. RESULTS: Nine topics considered most important and frequent were reviewed as standalone topics (interstitial lung abnormalities, emphysema, bronchiectasis, consolidation, coronary calcification, aortic valve disease, mediastinal mass, mediastinal lymph nodes and thyroid abnormalities). Other topics considered of lower importance or infrequent were grouped into generic categories, suitable for general statements. CONCLUSIONS: This European collaborative group has produced an incidental findings statement that can be followed during lung cancer screening. It will ensure that an evidence-based approach is used for reporting and managing incidental findings, which will mean that harms are minimised and any programme is as cost-effective as possible.
Azienda Ospedaliero Universitaria Maggiore della Carità di Novara Novara Italy
Bayer AG Research and Development Pharmaceuticals Radiology Berlin Germany
Christian Albrechts Universität zu Kiel Faculty of Medicine Kiel Germany
Cochin Hospital APHP Radiology Department Paris France
European Lung Foundation Tipton UK
Galway Clinic Doughiska Galway Ireland
German Center for Lung Research DZL Translational Lung Research Center TLRC Heidelberg Germany
HELIOS Klinikum Emil von Behring GmbH Lungenklinik Heckeshorn Berlin Germany
Humanitas Research Hospital Division of Thoracic and General Surgery Rozzano Italy
Inselspital Universitatsspital Bern Radiation Oncology Bern Switzerland
Institute of Tuberculosis and Lung Diseases Warsaw Genetics and Clinical Immunology Warsaw Poland
Kantonsspital Sankt Gallen Radiation Oncology Sankt Gallen Switzerland
Kliniken Maria Hilf GmbH Monchengladbach Nordrhein Westfalen Germany
Medical Centre Leeuwarden Department of Respiratory Medicine Leeuwarden The Netherlands
National Koranyi Institute of Pulmonology Department of Radiology Budapest Hungary
Nottingham University Hospitals NHS Trust Department of Respiratory Medicine Nottingham UK
Nottingham University Hospitals NHS Trust Nottingham UK
Radboud University Nijmegen Medical Center Department of Radiology Nijmegen The Netherlands
Royal Brompton and Harefield NHS Foundation Trust Radiology London UK
Sotiria General Hospital of Chest Diseases of Athens Respiratory Medicine Athens Greece
St James's University Hospital Department of Thoracic Surgery Leeds UK
UMCG Groningen The Netherlands
Universitaire Ziekenhuizen Leuven Radiology Leuven Belgium
UniversitatsKlinikum Heidelberg Heidelberg Germany
Université de Paris Paris France
University College Dublin School of Medicine Histopathology Dublin Ireland
University Hospital Antwerp Radiology Edegem Belgium
University Hospital of Salamanca Thoracic Surgery Salamanca Spain
University Hospitals Leuven Thoracic Surgery Leuven Belgium
University of Heidelberg Diagnostic and Interventional Radiology Heidelberg Germany
University of Latvia Faculty of Medicine Riga Latvia
University of Nottingham Faculty of Medicine and Health Sciences Nottingham UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001088
- 003
- CZ-PrNML
- 005
- 20240716080930.0
- 007
- ta
- 008
- 240109s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ejcts/ezad302 $2 doi
- 035 __
- $a (PubMed)37804174
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a O'Dowd, Emma L $u Nottingham University Hospitals NHS Trust, Nottingham, UK $u University of Nottingham, Faculty of Medicine and Health Sciences, Nottingham, UK
- 245 10
- $a ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer / $c EL. O'Dowd, I. Tietzova, E. Bartlett, A. Devaraj, J. Biederer, M. Brambilla, A. Brunelli, J. Chorostowska, H. Decaluwe, D. Deruysscher, W. De Wever, M. Donoghue, A. Fabre, M. Gaga, W. van Geffen, G. Hardavella, HU. Kauczor, A. Kerpel-Fronius, J. van Meerbeeck, B. Nagavci, U. Nestle, N. Novoa, H. Prosch, M. Prokop, PM. Putora, J. Rawlinson, MP. Revel, A. Snoeckx, G. Veronesi, R. Vliegenthart, S. Weckbach, TG. Blum, DR. Baldwin
- 520 9_
- $a BACKGROUND: Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that will ensure clinical and cost effectiveness. This European Respiratory Society (ERS) task force was formed to provide an expert consensus for the management of incidental findings which can be adapted and followed during implementation. METHODS: A multi-European society collaborative group was convened. 23 topics were identified, primarily from an ERS statement on lung cancer screening, and a systematic review of the literature was conducted according to ERS standards. Initial review of abstracts was completed and full text was provided to members of the group for each topic. Sections were edited and the final document approved by all members and the ERS Science Council. RESULTS: Nine topics considered most important and frequent were reviewed as standalone topics (interstitial lung abnormalities, emphysema, bronchiectasis, consolidation, coronary calcification, aortic valve disease, mediastinal mass, mediastinal lymph nodes and thyroid abnormalities). Other topics considered of lower importance or infrequent were grouped into generic categories, suitable for general statements. CONCLUSIONS: This European collaborative group has produced an incidental findings statement that can be followed during lung cancer screening. It will ensure that an evidence-based approach is used for reporting and managing incidental findings, which will mean that harms are minimised and any programme is as cost-effective as possible.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory plic $x diagnostické zobrazování $7 D008175
- 650 _2
- $a časná detekce nádoru $x metody $7 D055088
- 650 _2
- $a exprimované sekvenční adresy $7 D020224
- 650 _2
- $a náhodný nález $7 D033162
- 650 _2
- $a počítačová rentgenová tomografie $x metody $7 D014057
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tietzová, Ilona $u Charles University, First Faculty of Medicine, Department of Tuberculosis and Respiratory Diseases, Prague, Czech Republic $7 xx0319619
- 700 1_
- $a Bartlett, Emily $u Royal Brompton and Harefield NHS Foundation Trust, Radiology, London, UK
- 700 1_
- $a Devaraj, Anand $u Royal Brompton and Harefield NHS Foundation Trust, Radiology, London, UK
- 700 1_
- $a Biederer, Jürgen $u University of Heidelberg, Diagnostic and Interventional Radiology, Heidelberg, Germany $u German Center for Lung Research DZL, Translational Lung Research Center TLRC, Heidelberg, Germany $u University of Latvia, Faculty of Medicine, Riga, Latvia $u Christian-Albrechts-Universität zu Kiel, Faculty of Medicine, Kiel, Germany
- 700 1_
- $a Brambilla, Marco $u Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara, Novara, Italy
- 700 1_
- $a Brunelli, Alessandro $u St. James's University Hospital, Department of Thoracic Surgery, Leeds, UK
- 700 1_
- $a Chorostowska, Joanna $u Institute of Tuberculosis and Lung Diseases, Warsaw, Genetics and Clinical Immunology, Warsaw, Poland $1 https://orcid.org/0000000317432961
- 700 1_
- $a Decaluwe, Herbert $u University Hospitals Leuven, Thoracic Surgery, Leuven, Belgium $1 https://orcid.org/0000000208777717
- 700 1_
- $a Deruysscher, Dirk $u Maastricht University Medical Centre, Department of Radiation Oncology (MAASTRO Clinic), GROW-School for Oncology and Developmental Biology, Limburg, The Netherlands
- 700 1_
- $a De Wever, Walter $u Universitaire Ziekenhuizen Leuven, Radiology, Leuven, Belgium
- 700 1_
- $a Donoghue, Matthew $u Galway Clinic Doughiska, Galway, Ireland
- 700 1_
- $a Fabre, Aurelie $u University College Dublin School of Medicine, Histopathology, Dublin, Ireland
- 700 1_
- $a Gaga, Mina $u Sotiria General Hospital of Chest Diseases of Athens, 7th Respiratory Medicine Department, Athens, Greece $1 https://orcid.org/0000000299496012
- 700 1_
- $a van Geffen, Wouter $u Medical Centre Leeuwarden, Department of Respiratory Medicine, Leeuwarden, The Netherlands $u University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, Groningen, The Netherlands $1 https://orcid.org/0000000259760974
- 700 1_
- $a Hardavella, Georgia $u Sotiria General Hospital of Chest Diseases of Athens, Respiratory Medicine, Athens, Greece
- 700 1_
- $a Kauczor, Hans-Ulrich $u University of Heidelberg, Diagnostic and Interventional Radiology, Heidelberg, Germany $u German Center for Lung Research DZL, Translational Lung Research Center TLRC, Heidelberg, Germany
- 700 1_
- $a Kerpel-Fronius, Anna $u National Koranyi Institute of Pulmonology, Department of Radiology, Budapest, Hungary $1 https://orcid.org/0000000286163366
- 700 1_
- $a van Meerbeeck, Jan $u UZ Antwerpen, MOCA, Edegem, Belgium $1 https://orcid.org/0000000178728622
- 700 1_
- $a Nagavci, Blin $u Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
- 700 1_
- $a Nestle, Ursula $u Kliniken Maria Hilf GmbH Monchengladbach, Nordrhein-Westfalen, Germany
- 700 1_
- $a Novoa, Nuria $u University Hospital of Salamanca, Thoracic Surgery, Salamanca, Spain
- 700 1_
- $a Prosch, Helmut $u Medical University of Vienna, Department of Biomedical Imaging and Image-guided Therapy, Vienna, Austria $1 https://orcid.org/0000000261196364
- 700 1_
- $a Prokop, Mathias $u Radboud University Nijmegen Medical Center, Department of Radiology, Nijmegen, The Netherlands
- 700 1_
- $a Putora, Paul Martin $u Kantonsspital Sankt Gallen, Radiation Oncology, Sankt Gallen, Switzerland $u Inselspital Universitatsspital Bern, Radiation Oncology, Bern, Switzerland
- 700 1_
- $a Rawlinson, Janette $u European Lung Foundation, Tipton, UK
- 700 1_
- $a Revel, Marie-Pierre $u Cochin Hospital, APHP, Radiology Department, Paris, France $u Université de Paris, Paris, France $1 https://orcid.org/0000000182137817
- 700 1_
- $a Snoeckx, Annemiek $u University Hospital Antwerp, Radiology, Edegem, Belgium
- 700 1_
- $a Veronesi, Giulia $u Humanitas Research Hospital, Division of Thoracic and General Surgery, Rozzano, Italy
- 700 1_
- $a Vliegenthart, Rozemarijn $u UMCG, Groningen, The Netherlands
- 700 1_
- $a Weckbach, Sabine $u UniversitatsKlinikum Heidelberg, Heidelberg, Germany $u Bayer AG, Research and Development, Pharmaceuticals, Radiology, Berlin, Germany
- 700 1_
- $a Blum, Torsten G $u HELIOS Klinikum Emil von Behring GmbH, Lungenklinik Heckeshorn, Berlin, Germany
- 700 1_
- $a Baldwin, David R $u University of Nottingham, Faculty of Medicine and Health Sciences, Nottingham, UK $u Nottingham University Hospitals NHS Trust, Department of Respiratory Medicine, Nottingham, UK $1 https://orcid.org/0000000184107160
- 773 0_
- $w MED00001607 $t European journal of cardio-thoracic surgery $x 1873-734X $g Roč. 64, č. 4 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37804174 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240716080927 $b ABA008
- 999 __
- $a ok $b bmc $g 2049599 $s 1210782
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 64 $c 4 $e 2023Oct04 $i 1873-734X $m European journal of cardio-thoracic surgery $n Eur J Cardiothorac Surg $x MED00001607
- GRA __
- $a TF-2019-14 $p European Respiratory Society
- LZP __
- $a Pubmed-20240109
